U.S. bans Indian drugmaker Divi's factory, shares hit 3-year low

MUMBAI (Reuters) - U.S. health regulators have banned a drug production site in India belonging to Divi's Laboratories Ltd due to manufacturing violations, sending the company's shares down to a near three-year low on Wednesday.